1. Home
  2. TBLA vs ANIP Comparison

TBLA vs ANIP Comparison

Compare TBLA & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBLA
  • ANIP
  • Stock Information
  • Founded
  • TBLA 2007
  • ANIP 2001
  • Country
  • TBLA United States
  • ANIP United States
  • Employees
  • TBLA N/A
  • ANIP N/A
  • Industry
  • TBLA Computer Software: Programming Data Processing
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • TBLA Technology
  • ANIP Health Care
  • Exchange
  • TBLA Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • TBLA 1.2B
  • ANIP 1.4B
  • IPO Year
  • TBLA N/A
  • ANIP N/A
  • Fundamental
  • Price
  • TBLA $3.76
  • ANIP $65.31
  • Analyst Decision
  • TBLA Strong Buy
  • ANIP Strong Buy
  • Analyst Count
  • TBLA 4
  • ANIP 8
  • Target Price
  • TBLA $4.50
  • ANIP $80.13
  • AVG Volume (30 Days)
  • TBLA 1.5M
  • ANIP 246.6K
  • Earning Date
  • TBLA 08-06-2025
  • ANIP 08-05-2025
  • Dividend Yield
  • TBLA N/A
  • ANIP N/A
  • EPS Growth
  • TBLA N/A
  • ANIP N/A
  • EPS
  • TBLA 0.04
  • ANIP N/A
  • Revenue
  • TBLA $1,779,705,000.00
  • ANIP $674,068,000.00
  • Revenue This Year
  • TBLA $7.69
  • ANIP $30.52
  • Revenue Next Year
  • TBLA $6.15
  • ANIP $7.40
  • P/E Ratio
  • TBLA $94.36
  • ANIP N/A
  • Revenue Growth
  • TBLA 16.63
  • ANIP 30.27
  • 52 Week Low
  • TBLA $2.50
  • ANIP $52.50
  • 52 Week High
  • TBLA $4.30
  • ANIP $77.00
  • Technical
  • Relative Strength Index (RSI)
  • TBLA 58.42
  • ANIP 55.12
  • Support Level
  • TBLA $3.62
  • ANIP $63.17
  • Resistance Level
  • TBLA $3.72
  • ANIP $66.18
  • Average True Range (ATR)
  • TBLA 0.10
  • ANIP 1.83
  • MACD
  • TBLA -0.01
  • ANIP 0.00
  • Stochastic Oscillator
  • TBLA 83.33
  • ANIP 54.23

About TBLA Taboola.com Ltd.

Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, Germany, France, Rest of the world whilst it generates the majority of its revenue from the United States.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: